LATEST
Janel agreed to acquire EnCor BiotechnologyNightfood Holdings acquired Jun Long Machine IndustrialClimb Global Solutions acquired NeoVADValor Energy agreed to acquire Glorious StarOakley Capital / Global Loan Agency ServicesTA Associates / MedEnvision: majority stakeLSEG agreed to acquire OctusStord / AMS Fulfillment: investmentCencora agreed to acquire American Oncology NetworkAPEX / KoraiSmith & Wesson Brands agreed to acquire Long Range IntermediateBose acquired Skullcandy
Open App
Agreement signedPublished 4 Apr 2022

Castle Biosciences, Inc. /
AltheaDx, Inc.

Castle Biosciences to acquire AltheaDx in merger agreement

Price
$32.5m
Stage
Agreement signed
Source · 4 Apr 2022
See the source
01 / BuyerCastle Biosciences, Inc.
02 / TargetAltheaDx, Inc.
01

What happened

Castle Biosciences, Inc. agreed to acquire AltheaDx, Inc. through a merger, with AltheaDx continuing as a wholly owned subsidiary of Castle Biosciences.

The consideration includes $32.5 million in cash and $32.5 million in Castle Biosciences common stock, plus up to $75.0 million in milestone payments. AltheaDx provides pharmacogenomics testing services focused on mental health.

02

The source

Everything on this page comes from the source below.

01
Source · Source

Castle Biosciences to acquire AltheaDx in merger agreement

This document is the source for the companies, stage, figure and people on this page.

Original filingUnlock with Pro
03

Timeline

Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.

  1. Published by the source

    The source this page is built from.

The same firms, in other deals

The firms' deal history and connections across other deals.

These firms' full profiles are part of Pro.

Request accessAlready invited? Sign in

Carrywatch Pro is by invitation. An invite lets you buy Pro.